(Q37975644)

26 August 2017

1 reference

26 September 2020

1 reference

PubMed publication ID

22244200

systematic review

1 reference

PubMed publication ID

22244200

title

Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis (English)

1 reference

26 August 2017

hepatocellular carcinoma

1 reference

26 September 2020

1 reference

26 September 2020

1 reference

7 August 2019

1 reference

15 December 2019

1 reference

26 September 2020

1 reference

1 reference

Ying Zhou

1

1 reference

26 August 2017

Xin Yin

series ordinal

2

1 reference

26 August 2017

Jun Ying

series ordinal

3

1 reference

26 August 2017

Boheng Zhang

series ordinal

4

1 reference

26 August 2017

language of work or name

English

0 references

publication date

16 January 2012

8 references

26 August 2017

3 April 2019

19 June 2019

7 August 2019

27 November 2019

13 December 2019

15 December 2019

26 September 2020

8 references

26 August 2017

3 April 2019

19 June 2019

7 August 2019

27 November 2019

13 December 2019

15 December 2019

26 September 2020

12

1 reference

26 August 2017

17

1 reference

Creative Commons Attribution 2.0 Generic

26 August 2017

7 references

3 April 2019

19 June 2019

7 August 2019

27 November 2019

13 December 2019

15 December 2019

on focus list of Wikimedia project

26 September 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

New perspectives and strategy research biomarkers for hepatocellular carcinoma.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

No role for quality scores in systematic reviews of diagnostic accuracy studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Sources of variation and bias in studies of diagnostic accuracy: a systematic review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Approaches to heterogeneity in meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Phases of biomarker development for early detection of cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

GP73, a novel Golgi-localized protein upregulated by viral infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

[Correlaion between serum Golph2 protein and hepatocellular carcinoma].

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Efficacy of a surveillance program for early detection of hepatocellular carcinoma.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

RETRACTED: Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292967

Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

1 September 2018

1 reference

12 December 2020

GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma

1 reference

12 December 2020

A concise review of serum markers for hepatocellular cancer

1 reference

12 December 2020

Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma

1 reference

12 December 2020

Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas

1 reference

12 December 2020

Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma

1 reference

12 December 2020

AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC

1 reference

12 December 2020

Value of Golgi protein 73 monoclonal antibody in diagnosis of hepatocellular carcinoma

1 reference

12 December 2020

A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-12-17

1 reference

Dimensions Publication ID

26 August 2017

0 references

1 reference

26 August 2017

PubMed publication ID

22244200

1 reference